title: Systemic lupus erythematosus in 2013. Taking a closer look at biologic therapy for SLE.
abstract: Clinical, basic and translational research in systemic lupus erythematosus are fast-moving fields. 2013 has seen the publication of some potentially landmark papers, which not only explore the potential of novel agents but also glean new insights from past trials.
authors.affiliation: Centre for Rheumatology, University College London, Room 424, 4th Floor Rayne Building, 5 University Street, London WC1E 6JF, UK.
authors.forename: David A
authors.initials: DA
authors.lastname: Isenberg
authors.affiliation: Centre for Rheumatology, University College London, Room 424, 4th Floor Rayne Building, 5 University Street, London WC1E 6JF, UK.
authors.forename: Anisur
authors.initials: A
authors.lastname: Rahman
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D001691:Biological Therapy; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D000069283:Rituximab; D057170:Translational Research, Biomedical; D016896:Treatment Outcome
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D058846:Antibodies, Monoclonal, Murine-Derived; C448700:epratuzumab; D000069283:Rituximab; D009173:Mycophenolic Acid